U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07219693) titled 'QuantaFlo HD Clinical Validation Study' on Oct. 20.
Brief Summary: The primary aim of this validation protocol is to assess cardiovascular function through transthoracic echocardiography ("Echo") measurements and the QuantaFlo HD test measuring blood flow at the finger during a forced expiration ("FE"). The study examines whether Echo-measured GLS values greater than -16% correlate with abnormal responses during FE as measured by QuantaFlo HD.
Study Start Date: Aug. 21
Study Type: OBSERVATIONAL
Condition:
To Assess Cardiovascular Function
Intervention:
DEVICE: QuantaFlo HD
blood flow at the finger during a forced expiration
...